Crossmark

Patients’ knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee

Crossref DOI link: https://doi.org/10.1186/s12913-018-2968-2

Published Online: 2018-03-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bastholm-Rahmner, Pia

Gustafsson, Lars L.

Aggefors, Kristina

Ateva, Kristina

Elfving, Susanne

Eriksen, Jaran

Jirlow, Malena

Juhasz-Haverinen, Maria

Malmström, Rickard E.

Nikpour-Ardaly, Mahan

Röjvall, Magnus

Vallin, Martina

Andersén-Karlsson, Eva

Ovesjö, Marie-Louise
License Information

Text and Data Mining valid from 2018-03-12
More Information

Article History

Received: 4 April 2017

Accepted: 27 February 2018

First Online: 12 March 2018

Competing interests

: The authors declare that they have no competing interest.

: This project was part of on-going quality improvement work at Stockholm healthcare region. All handling in this study is complied with Swedish legislation and no application for approval by the Regional Institutional Review Board was needed. In the survey respondents were informed about the aim of the study and thereafter asked if they wanted to participate. In the focus groups discussions all respondents gave their written consent to participate.

: Not applicable.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.